Seelos Therapeutics (SEEL) SEC Filings & 10K Form

$0.29
-0.01 (-3.34%)
(As of 05/8/2024 ET)

Recent Seelos Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2024
7:30 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-K/A
03/28/2024
7:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2024
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
03/06/2024
4:32 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-1/A
03/06/2024
3:50 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2024
4:39 PM
Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:26 PM
Lind Global Fund II LP (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Form SC 13G
02/02/2024
5:04 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/30/2024
3:01 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:05 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
01/22/2024
7:05 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
8:47 PM
Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
8:47 PM
Mehra Raj (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:16 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
8:45 PM
O'Connor Daniel J. (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:45 PM
Lian Brian (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:45 PM
DALESANDRO MARGARET (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:46 PM
Pascoe Richard W (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:10 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/27/2023
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
12/22/2023
3:01 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:10 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/20/2023
3:54 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/20/2023
3:59 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/18/2023
3:54 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/01/2023
3:08 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
3:58 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
11/30/2023
3:59 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
8:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
11:07 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
10:10 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2023
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
10/02/2023
5:03 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:06 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
5:02 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
09/20/2023
6:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
3:15 PM
Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:05 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2023
8:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SEEL) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners